Whitepapers

Portfolio co-positioning refers to the commercialization of one or more assets by the same company in the same area. Determining which asset is targeted to which patient segment requires a robust and objective process. So, what is the best practice approach to portfolio co-positioning?

...we must from time to time take stock of the trajectory upon which cancer therapy seems destined to follow.  Why?...

In this piece, Renu and Matthew break down why the market has failed to tackle antimicrobial resistance and look into some of the initiatives created to deal with the problem. Focusing on England’s novel payment evaluation and purchasing frameworks, they investigate how the new ‘de-linked’ approach could impact the development of future treatments.